Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment.
about
An in vivo and in vitro toxicological characterisation of realistic nanoscale CeO2 inhalation exposuresDirect stimulation of human fibroblasts by nCeO2 in vitro is attenuated with an amorphous silica coatingEnzymatic oxidative biodegradation of nanoparticles: mechanisms, significance and applicationsMutagenic Effects of Iron Oxide Nanoparticles on Biological CellsImmunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulationInorganic nanosystems for therapeutic delivery: status and prospectsThe big picture on nanomedicine: the state of investigational and approved nanomedicine productsTargeted therapy using nanotechnology: focus on cancerPlasma proteins interaction with curcumin nanoparticles: implications in cancer therapeuticseNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessmentTransport of Gold Nanoparticles by Vascular Endothelium from Different Human TissuesProtein Adsorption Alters Hydrophobic Surfaces Used for Suspension Culture of Pluripotent Stem Cells.Adsorption and Unfolding of a Single Protein Triggers Nanoparticle AggregationImproving cell-based therapies by nanomodificationThe impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug deliveryCatalytic Properties and Biomedical Applications of Cerium Oxide NanoparticlesCarbon black and titanium dioxide nanoparticles induce distinct molecular mechanisms of toxicityBeyond the passive interactions at the nano-bio interface: evidence of Cu metalloprotein-driven oxidative dissolution of silver nanoparticlesThe effect of blood protein adsorption on cellular uptake of anatase TiO2 nanoparticlesQuantification of the cellular dose and characterization of nanoparticle transport during in vitro testingTissue distribution and acute toxicity of silver after single intravenous administration in mice: nano-specific and size-dependent effectsToxicity of engineered nanomaterials: a physicochemical perspectiveEffects of serum on cytotoxicity of nano- and micro-sized ZnO particlesIntracellular signal modulation by nanomaterialsEnvironmental impact of multi-wall carbon nanotubes in a novel model of exposure: systemic distribution, macrophage accumulation, and amyloid depositionTrojan-Like Internalization of Anatase Titanium Dioxide Nanoparticles by Human Osteoblast CellsQuantitative analysis of nanoparticle transport through in vitro blood-brain barrier modelsNanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomesNanoparticle Uptake: The Phagocyte ProblemDynamics of nanoparticle-protein corona complex formation: analytical results from population balance equationsSilver nanoparticle protein corona composition in cell culture mediaPlasma protein corona modulates the vascular wall interaction of drug carriers in a material and donor specific mannerFrom Dose to Response: In Vivo Nanoparticle Processing and Potential Toxicity.Provenance information as a tool for addressing engineered nanoparticle reproducibility challengesMetal Oxide Nanomaterial QNAR Models: Available Structural Descriptors and Understanding of Toxicity MechanismsUnderstanding Protein Structure Deformation on the Surface of Gold Nanoparticles of Varying Size.Secondary structure of corona proteins determines the cell surface receptors used by nanoparticles.Of drug administration, war and oïkos: mediating cancer with nanomedicines.Allosteric effects of gold nanoparticles on human serum albumin.Surface-grafted polysarcosine as a peptoid antifouling polymer brush.
P2860
Q23919511-1B42B532-8731-425E-B7D5-16343BB9261EQ26343837-807D19C5-9C0D-4206-B184-1A52D5044951Q26345200-47AC80CA-8B82-4A20-8C17-C2F744A081C9Q26782085-4BA3B366-EAF4-4D08-A490-D366A1D70411Q26825654-CE4EFC59-0784-400F-9FB6-9A31A24AD590Q26827968-0E9DBE16-88FF-4B99-892A-13240E484716Q27021817-18EBE1F7-2758-42E9-8AE7-0CC14D6F64ABQ27023361-1A931319-874F-47B8-8536-770C5D4EBE73Q27026623-E848F157-2BC8-4832-AC72-A360B4CD21A3Q27062683-DD9D988E-3046-4305-84FD-14611E99B6E9Q27325382-0B820B67-C974-489C-8557-AC51C86DA940Q27335441-177BB946-D9B7-4553-9457-29AD6B571E86Q27341824-F63341D2-EC0C-4452-A76A-C0A1B831EE12Q28080427-3B1F9F68-3703-41EA-9691-85A91679018BQ28085280-9FAF5F35-8406-4ABA-A70D-815200C23E46Q28383937-01A507A2-8102-4007-B26E-C4559FAF55FFQ28384562-138872BF-8EB3-4C8E-A58E-1BF83EB7761FQ28384716-3A2257F0-ACF1-4218-AE75-F55F63ECAC1CQ28386401-74B52B80-64FC-4E08-B994-602D39914C59Q28387370-2B98C89F-1039-4F36-B2AD-349CBFBF4997Q28388396-901F3ECE-29AE-4DF4-993C-0B2420740776Q28388891-7BDFE2E4-6F40-4AB6-9980-01461D7F4905Q28389059-F45B69C6-3163-44A2-A1AC-7CABCBA95ABDQ28390114-367BAC80-C847-4927-9ED2-AB7B28A5C67EQ28390669-19D68BB5-7785-40DB-9A31-4512E88FDDC1Q28390799-FA676B1E-BCBB-42BC-B67F-EDDDBE859213Q28392542-0BD1E3F6-B238-4124-8D72-7B129AA45855Q28392765-FFB00615-5B38-45D0-B888-AB82538E7F41Q28395287-5DBC9844-C1A6-47BE-8AF8-7E2CAAF60339Q28533556-A488E405-438C-4C06-B7B7-91C41027BF80Q28536934-299EBD3B-1B6D-45BF-AA44-23DB007F16BAQ28543040-1CD714D6-BF11-40E6-9016-0C0DBDB5ABFFQ28950609-C7A99E04-CECF-476C-B8EC-8D527BABE7A1Q29048614-C980FC69-8EE0-4272-AC44-57969D56D5EBQ29248772-519626D6-E116-44F1-9ED3-D732C67DCFEDQ30008757-75FD1665-7443-4581-929F-8AE86BFC5CABQ30361890-5F97F928-B85C-45E9-8502-68983864F672Q30380301-1361AE93-DBFF-4049-AEC0-3E8BE1F5DC27Q30396113-40B2ABB2-9E96-46E0-A8FE-1B6C3E821437Q30530726-14474802-92A1-4D4A-966E-31B42B64F47E
P2860
Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Understanding and controlling ...... n a physiological environment.
@en
Understanding and controlling ...... n a physiological environment.
@nl
type
label
Understanding and controlling ...... n a physiological environment.
@en
Understanding and controlling ...... n a physiological environment.
@nl
prefLabel
Understanding and controlling ...... n a physiological environment.
@en
Understanding and controlling ...... n a physiological environment.
@nl
P356
P1476
Understanding and controlling ...... n a physiological environment.
@en
P2093
Carl D Walkey
Warren C W Chan
P304
P356
10.1039/C1CS15233E
P577
2011-11-15T00:00:00Z